Rationale Malignant pleural mesothelioma is an almost universally fatal malignancy
primarily related to asbestos exposure. Based on the differences in immunologic markers …

Background The prognosis of malignant pleural mesothelioma has traditionally been poor.
Whether this remains the case compared to historical data and within a specific …

Background Malignant pleural mesothelioma (MPM) remains an aggressive malignancy that
is difficult to cure. However, the treatment paradigm of MPM has evolved, and the national …

PURPOSE Identification of prognostic factors in patients with malignant pleural
mesothelioma based on prospectively collected international data. PATIENTS AND …

Malignant pleural mesothelioma is an aggressive thoracic malignancy associated with
exposure to asbestos, and its incidence is anticipated to increase during the first half of this …

Introduction For the 3 histologic subtypes of malignant pleural mesothelioma (MPM)—
epithelioid, sarcomatoid, and biphasic—the magnitude of benefit with surgical management …

Malignant pleural mesothelioma (MPM) is a primary and locally aggressive tumor of the
pleura. A well defined causal relationship with asbestos exposure, and an overwhelming …

Abstract On March 28–29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy
Steering Committee, International Association for the Study of Lung Cancer, and …

Simple Summary Malignant pleural mesothelioma is an invasive and drug-resistant tumor
related to asbestos exposure, with limited therapy options. It is associated with an …

Objectives Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer with a
poor prognosis and limited treatment options. This study assessed the characteristics …